Eterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors
Dorothy Clarke Dorothy Clarke CAMBRIDGE, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the...
Read moreDorothy Clarke Dorothy Clarke CAMBRIDGE, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the...
Read moreStudy Shows SteraMist iHP Treatment of Beeswax Solid Substrates Greatly Reduced Deformed Wing Virus an RNA virus causing Honey Bee...
Read moreNumber of Director Seats to be Reduced to SevenMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Sept. 05, 2023 (GLOBE...
Read moreCOLUMBUS, Ohio, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) announced today that Gina Boswell,...
Read moreMIAMI, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...
Read moreEmphasis on Safety and Quality—Two Tools for Manufacturers to Rely on Win in the Industrial X-ray Films Market.NEWARK, Del, Sept....
Read moreMartin Huber, M.D., to leave Xilio Therapeutics and remain an advisorWALTHAM, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics,...
Read moreSOUTH SAN FRANCISCO, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
Read moreSAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., Ambrx (or the “Company”) (NASDAQ: AMAM), today announced that...
Read moreNEW YORK and TOKYO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a...
Read more